1 |
A. Seth, Y. Onuma, R. Costa, P. Chandra, V. K. Bahl, and C. N. Manjunath, First-in-human evaluation of a novel poly(L-lactide) based sirolimus-eluting bioresrobable vascular scaffold for the treatment of de novo native coronary artery lesions: meRes-1 trial. Eurointervention, 13, 415-423 (2017).
DOI
|
2 |
Y. Wu, L. Shen, Q. Wang, L. Ge, J. Xie, and X. Hu, Comparison of acute recoil between bioabsorbable poly(L-lactic acid) XINSORB stent and metallic stent in porcine model, J. Biomed. Biotechnol., 2012, 1-8 (2012).
|
3 |
Y. Zhang, C. V. Bourantas, V. Farooq, T. Muramastsu, R. Diletti, Y. Onuma, H. M. Garcia, and P. W. Serruys, Bioresorbable scaffolds in the treatment of coronary artery disease, Med. Devices (Auckl.), 6, 37-48 (2013).
|
4 |
C. Rapetto and M. Leoncini, Margmaris: A new generation metallic sirolimus-eluting fully bioresorbable scaffold: present status and futrue perspectives, J. Thorac. Dis., 9, S903-S913 (2017).
DOI
|
5 |
S. McMahon, N. Bertolo, E. D. O'Cearbhaill, J. Salber, L. Pierucci, P. Duffy, T. Durig, V. Bi, and W. Wang, Bio-resorbable polymer stents: a review of material progress and prospects, Prog. Polym. Sci., 83, 79-96 (2018).
DOI
|
6 |
A. Abizaid, D. Carrie, N. Frey, M. Lutz, J. Weber-Albers, and D. Dudek, 6-Month clinical and angiographic outcomes of a novel radio radiopaque sirolimus-eluting bioresorbable vascualr scaffold: the FANTOM II study, JACC Cadiovac. Interv., 10, 1832-1838 (2017).
DOI
|
7 |
W. Schmidt, P. Behrens, C. Brandt-Wunderlich, S. Siewert, N. Grabow, and K. P. Schmitz, In vitro performance investigation of bioresorbable scaffolds-Standard test for vascular stents and beyond, Cardiovasc. Revasc. Med., 17, 375-383 (2016).
DOI
|
8 |
C. Campos, Y. Zhanh, C. Boutantas, T. Muramatsu, H. Garcia, P. Lemos, Y. Onuma, and P. W. Serruys, Bioresorbable vascular scaffolds in the clinical setting. J. Interv. Cardiol., 5, 639-646 (2013).
DOI
|
9 |
A. Abizaid, First report on the pivotal DESolve Nx trial: 6-month clinical and multi-modality imaging results, presented in EuroPCR 2013, May 21, Paris, France (2013).
|
10 |
B. D. Gogas, Bioresorbable scaffolds for percutaneous coronary interventions, Glob. Cardiol. Sci. Pract., 40, 409-427 (2014).
|
11 |
T. P. Vahl, P. Gasior, C. A. Gongora, K. Ramzipoor, C. Lee, and Y. Cheong, Four-year polymer biocompatiblity and vascular scaffold: An OCT study in healthy procine coronary arteries, Eurointervention, 12, 1510-1518 (2016).
DOI
|
12 |
A. S. Rao, M. S. Makaroun, L. K. Marone, J. S. Cho, R. Rhee, and R. A. Chaer, Long-term otucomes of internal carotid artery dissection, Stroke, 40, 499-504 (2009).
DOI
|
13 |
E. Tenekecioglu, P. W. Serruys, Y. Onuma, R. Costa, D. Chamie, Y. Sotomi, T. B. Yu, A. Abizaid, H. B. Liew, and T. Santoso, Randomized comparsion of Absorb bioresorbable vascular scaffold and Mirage microfiber sirolimus-eluting scaffold using multimodality imaging, JACC Cadiovasc. Interv., 10(11), 1115-1130 (2017).
DOI
|
14 |
M. C. Chen, Y. Chang, C. T. Liu, W. Y. Lai, S. F. Peng, Y. W. Hung, H. W. Tasi, and H. Sung, The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents, Biomaterials, 30, 79-88 (2009).
DOI
|
15 |
S. A. Park, S. J. Lee, K. S. Lim, I. H. Bae, J. H. Lee, W. D. Kim, M. H. Jeong, and J. K. Park, In vivo evaluation and characterization of a bio-absorbable drug-coated stent fabricated using a 3D-printing system, Mater. Lett., 141, 355-358 (2015).
DOI
|
16 |
B. Gogas, V. Farooq, Y. Onuma, and P. W. Serruys, The ABSORB bioresorbable vascular scaffold an evolution or reverlution in interventional cardiology, Hellenic J. Cardiol., 53, 301-309 (2012).
|
17 |
G. L. Buchanan, S. Basavarajaiah, and A. Chieffo, Stent thrombosis: incidence, predictors and new technologies, Thrombosis, 2012, 956-962 (2012).
|
18 |
P. W. Serruys, Y. Onuma, H. M. Garcia, T. Muramatsu, R. J. vanGeuns, B. de Bruyne, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. M. Hebert, R. Rapoza, and J. A. Ormiston, Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months, Eurointervention, 9(11), 1271-1284 (2014).
DOI
|
19 |
P. Staehr, ABSORB bioresorbable vascular scaffold system. The 4th revolution in interventional cardiology, 17th Asian Harmonization Working Party Annual Conference, November 2-6, Taipei, Taiwan (2012).
|
20 |
D. Regazzoli, P. Leone, A. Colombo, and A. Latib, New generation bioresorbable scaffold technologies: An update on novel devices and clinical results, J. Thorac. Dis., 9, 979-985 (2017).
DOI
|
21 |
B. D. Gogas, Bioresorbable scaffolds for percutaneous coronary interventions, Glob. Cardiol. Sci. Pract., 40, 409-427 (2014).
|
22 |
A. Abizaid, R. A. Costa, and J. Schofer, Serial multimodality imaging and 2-year clinical outcomes of the novel DESolve novolimus-eluting bioresorbable coronary scaffold system for the treatment of single de novo coronary lesions, J. Am. Coll. Cardiol., 9, 565-574 (2016).
|
23 |
S. Verheye, J. A. Ormiston, J. Stewart, M. Webster, E. Sanidas, and R. Costa, A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation, JACC Cardiovasc. Interv., 7, 89-99 (2014).
DOI
|
24 |
M. Ying and Z. Chunjiao, Gloval Bioresorbable Vascular Scaffold Sales Market Report 2017, 1-129, QYResearch, CA, USA (2017).
|
25 |
J. Iqbal, Y. Ounuma, J. Ormistion, A. Abizaid, R. Wasksman, and P. W. Serruys, Bioresorbable scaffolds: rationale, current status, challenges, and future, Eur. Heart J., 35, 765-776 (2014).
DOI
|
26 |
Y. C. Lee, Health Industry Brief Medical Device Market Statistics: Stent, Korea Health Industry Development Institute, 52, 1-20 (2017).
|
27 |
H. Y. Ang, H. Bulluck, P. Wong, S. S. Venkatraman, Y. Huang, and N. Foin, Bioresrobable stent: Current and upcoming bioresorbable technologies, Int. J. Cardiol., 228, 931-939 (2017).
DOI
|
28 |
H. Hermawan, D. Dube, and D. Mantovani, Developments in metallic biodegradable stents, Acta Biomater, 6, 1693-1697 (2010).
DOI
|
29 |
C. Landau, R. A. Lange, and L. D. Hilis, Percutaneous transluminal coronary angioplasty, N. Engl. J. Med., 330, 981-993 (1994).
DOI
|